NVHR Press

 
 
Share this
 
 
Monday, February 3, 2014 - 14:28
Read NVHR's letter to medical providers regarding the appeals process to appeal insurance company denial of treatment using two new FDA approved drugs to treat chronic hepatitis C, Olysio (simeprevir) and Sovaldi (sofosbuvir)
Wednesday, November 27, 2013 - 11:22
Martha Saly Leaving Executive Director Post at National Viral Hepatitis Roundtable
Wednesday, September 11, 2013 - 11:46
The Corporate Hepatitis Alliance (CHA)Presents “The Silent Epidemic” Understanding hepatitis C (HCV) and the crisis among African American Communities Thursday September 19th 4:00 PM to 5:30 PM
Wednesday, August 21, 2013 - 06:28
Read about the honorees and their accomplishments.
Thursday, August 15, 2013 - 11:44
A revolution in health care is just weeks away. Since Congress passed the Affordable Care Act (ACA, a.k.a. “Obamacare”) in March 2010 and the Supreme Court validated most of the law in June 2012, the federal and state governments have been steadily laying the groundwork for a massive expansion of health insurance coverage. A signature goal is to greatly reduce the number of uninsured Americans, which in 2011 was a staggering 48.6 million, or 15.7 percent of the population.
Thursday, August 15, 2013 - 10:26
CDC MMWR Report: Locations and Reasons for Initial Testing for Hepatitis C Infection - Chronic Hepatitis Cohort Study, United States 2006 -2010 (see attached file, page 9)